Search
forResearch 10 of 1000+
- Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968)
- Novel therapies for alopecia areata: The era of rational drug development
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- Dupilumab: Friend or Foe to Alopecia Areata?
- Alopecia Areata: A Complex Cytokine Driven Disease
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- A novel therapeutic paradigm for patients with extensive alopecia areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →